Update on real-world efficacy of anlotinib in non-small cell lung cancer

被引：0
|
作者：
Gao, Junzhen
Xu, Yan
Liu, Yonggang
Liang, Li
Yu, Yan
Zhao, Dahai
Jin, Jiahui
Wang, Mengzhao
机构：
[1] Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China
[3] Baotou Tumor Hosp, Baotou, Peoples R China
[4] Peking Univ Third Hosp, Beijing, Peoples R China
[5] Harbin Med Canc Hosp, Harbin, Peoples R China
[6] Second Affiliated Hosp, Hefei, Peoples R China
[7] Affiliated Qingdao Cent Hosp, Qingdao, Peoples R China
[8] Peking Union Med Coll Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21173
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Real-world biomarker testing trends in metastatic non-small cell lung cancer (NSCLC).
    Clinton, Natasha
    Patel, Manish R.
    Ayars, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18728 - E18728
  • [42] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Kellie J. Ryan
    Karen E. Skinner
    Ancilla W. Fernandes
    Rajeshwari S. Punekar
    Melissa Pavilack
    Mark S. Walker
    Noam A. VanderWalde
    Medical Oncology, 2019, 36
  • [43] EVALUATION OF DOCETAXEL USE IN NON-SMALL CELL LUNG CANCER: REAL-WORLD HEALTH OUTCOMES
    Merino Almazan, Macarena
    Marin Pozo, Juan Francisco
    Duarte Perez, Juan Manuel
    FARMACIA, 2021, 69 (03) : 419 - 425
  • [44] Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort studyEpidemiology
    Helga H. Hektoen
    Kaitlyn M. Tsuruda
    Lars Fjellbirkeland
    Yngvar Nilssen
    Odd Terje Brustugun
    Bettina K. Andreassen
    British Journal of Cancer, 2025, 132 (1) : 93 - 102
  • [45] Immunotherapy for non-small cell lung cancer: from clinical trials to real-world practice
    Rashdan, Sawsan
    Gerber, David E.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (03) : 202 - 207
  • [46] Impact of Maintenance Therapy for Patients with Non-small Cell Lung Cancer in a Real-world Setting
    Yoh, Kiyotaka
    Goto, Yasushi
    Naito, Yoichi
    Kishi, Kazuma
    Mori, Kiyoshi
    Hotta, Katsuyuki
    Hosomi, Yukio
    Yamada, Kazuhiko
    Tanai, Chiharu
    Tomizawa, Yoshio
    Inoue, Akira
    Hasegawa, Yoshinori
    Nishio, Makoto
    Ohashi, Yasuo
    Kunitoh, Hideo
    ANTICANCER RESEARCH, 2017, 37 (03) : 1507 - 1513
  • [47] Real-world treatment patterns for metastatic non-small cell lung cancer at IRST Italy
    Altini, M.
    Massa, I.
    Balzi, W.
    Gentili, N.
    Foca, F.
    Danesi, V.
    Manunta, S.
    Burgio, M. A.
    Cravero, P.
    Ejzykowicz, F.
    Chandwani, S.
    Delmonte, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [48] Real-world efficacy and safety of anlotinib as third- or further-line treatment in refractory small cell lung cancer
    Xuetian Gao
    Ling Peng
    Li Zhang
    Kai Huang
    Cuihua Yi
    Bei Li
    Xue Meng
    Jisheng Li
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2661 - 2671
  • [49] Real-world efficacy and safety of anlotinib as third- or further-line treatment in refractory small cell lung cancer
    Gao, Xuetian
    Peng, Ling
    Zhang, Li
    Huang, Kai
    Yi, Cuihua
    Li, Bei
    Meng, Xue
    Li, Jisheng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2661 - 2671
  • [50] Lung Cancer Prognostic Index Performance in US Real-World Advanced Non-Small Cell Lung Cancer Patients
    Shah, R.
    John, A.
    Alexander, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S391 - S391
12345